The recent challenges in global distribution have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas producers exposes countries to potential vulnerabilities, including transportation delays, cost fluctuations, and even trade threats. Moving towards domestic production of Ivermectin offers a multitude